The role of weight and enteric coating on aspirin response in cardiovascular patients

1 Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI. Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 2008; 133: 141S–59S. 2 Crowther MA, Berry LR, Monagle PT, Chan AK. Mechanisms responsible for the failure of protamine to inactivate low-molecularweight heparin. Br J Haematol 2002; 116: 178–86. 3 Wiernikowski JT, Chan A, Lo G. Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin. Thromb Res 2007; 120: 303–5. 4 van den Besselaar AMHP, Sturk A, Reijnierse GLA. Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic ranges. Thromb Res 2002; 107: 235–40.

[1]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[2]  F. Santilli,et al.  Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". , 2009, Journal of the American College of Cardiology.

[3]  F. Sofi,et al.  Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events--a meta-analysis. , 2008, International journal of cardiology.

[4]  J. Hirsh,et al.  Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[5]  W Scott Beattie,et al.  Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis , 2008, BMJ : British Medical Journal.

[6]  J. Turgeon,et al.  A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. , 2007, European heart journal.

[7]  M. Cattaneo.  Laboratory detection of 'aspirin resistance': what test should we use (if any)? , 2007, European heart journal.

[8]  K. Mann,et al.  Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. , 2007, Blood.

[9]  B. Mertens,et al.  Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. , 2007, American heart journal.

[10]  Jeannie K. Lee,et al.  Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. , 2006, JAMA.

[11]  T. Lecompte.  Résistance à l’aspirine, G.J. Hankey, J. Eikelboom, in: Lancet, 367. (2006), 606 , 2006 .

[12]  M. Furman,et al.  Residual Arachidonic Acid–Induced Platelet Activation via an Adenosine Diphosphate–Dependent but Cyclooxygenase-1– and Cyclooxygenase-2–Independent Pathway: A 700-Patient Study of Aspirin Resistance , 2006, Circulation.

[13]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[14]  K. Schrör,et al.  Towards a definition of aspirin resistance: a typological approach , 2002, Platelets.

[15]  P. Monagle,et al.  Mechanisms responsible for the failure of protamine 
to inactivate low‐molecular‐weight heparin , 2002, British journal of haematology.

[16]  A. Chan,et al.  Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin. , 2007, Thrombosis research.

[17]  K. Bairy,et al.  Aspirin resistance. , 2007, Indian journal of physiology and pharmacology.

[18]  C. Patrono,et al.  Drug Insight: aspirin resistance—fact or fashion? , 2007, Nature Clinical Practice Cardiovascular Medicine.

[19]  F. Sebening,et al.  [Coronary artery disease]. , 1980, Verhandlungen der Deutschen Gesellschaft fur Herz- und Kreislaufforschung.

[20]  A. Maree,et al.  E-publications@rcsi Citation Attribution-non-commercial-sharealike 1.0 Volunteers Effect of Enteric Coating on Antiplatelet Activity of Low-dose Aspirin in Healthy Effect of Enteric Coating on Antiplatelet Activity of Low-dose Aspirin in Healthy Volunteers , 2022 .